CVS Health (NYSE: CVS) isn't having a good year. It is facing multiple headwinds and slow revenue growth, and investors are reacting in kind. The company's shares are down by 26% since January.
The Federal Trade Commission filed an action against the three largest prescription drug benefit managers or PBMs— CVS Health's ...
The Federal Trade Commission Friday announced it was suing the country's three biggest pharmacy benefit managers, claiming ...
On Friday, the Federal Trade Commission (FTC) filed a formal complaint against three major pharmacy benefit managers ...
The federal government is suing some pharmacy benefit managers over a system of drug rebates that regulators say has made the ...
The fall of 2023 was filled with frustration from customers across Kansas City forced to find new pharmacy options.
By Suzanne King The Beacon A year ago this week, 27 pharmacists walked off their jobs in and around Kansas City to protest ...
Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...
The FTC said CVS Caremark, Cigna’s Express Scripts, and UnitedHealth’s OptumRx profit at the expense of patients forced to ...
The U.S. Federal Trade Commission sued the country's three largest pharmacy benefit managers on Friday, accusing them of ...
The Federal Trade Commission took action Friday against the three largest pharmacy benefit managers, accusing the companies ...
Months earlier, the agency released a report alleging the companies drove up the costs of some medications, including insulin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback